Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Covalon Technologies Ltd.

Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference
From Covalon Technologies Ltd.
Via Business Wire
Tickers TSX-V:COV
Covalon Announces Profitable Second Quarter Fiscal 2024 Results
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Announces First Quarter Fiscal 2024 Results
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon’s VALGuard Gains Prestigious Recognition in the British Journal of Nursing
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Life with a Central Line [WEBINAR]: Key Considerations from the Patient’s Perspective
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Premier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Webinar on Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention, Presented by Covalon
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Breakthrough Solution for Fragile Skin: Covalon’s IV Clear® Dressing Recommended by Physicians at a Top 10 U.S. Children’s Hospital and Epidermolysis Bullosa Center of Excellence
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon, Leader in Compassionate Pediatric Infection Prevention Solutions, to Participate in Neonatal/Fetal Conference in Columbus, Ohio on May 17 - 19, 2023
From Covalon Technologies Ltd.
Via Business Wire
Tickers CVALF TSX-V:COV
Covalon Technologies to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021
From Covalon Technologies Ltd.
Via AccessWire
Exposures Product Safety
Tickers CVALF TSX-V:COV
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.